MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 156 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $157,000 | -24.5% | 11,264 | 0.0% | 0.12% | -27.4% |
| Q3 2017 | $208,000 | +9.5% | 11,264 | 0.0% | 0.16% | +5.8% |
| Q2 2017 | $190,000 | +26.7% | 11,264 | 0.0% | 0.16% | +28.1% |
| Q1 2017 | $150,000 | -11.8% | 11,264 | 0.0% | 0.12% | -10.4% |
| Q4 2016 | $170,000 | +28.8% | 11,264 | 0.0% | 0.14% | +20.5% |
| Q3 2016 | $132,000 | +8.2% | 11,264 | 0.0% | 0.11% | +7.7% |
| Q2 2016 | $122,000 | +17.3% | 11,264 | 0.0% | 0.10% | +16.9% |
| Q1 2016 | $104,000 | -37.7% | 11,264 | 0.0% | 0.09% | -38.2% |
| Q4 2015 | $167,000 | -9.7% | 11,264 | 0.0% | 0.14% | -14.3% |
| Q3 2015 | $185,000 | -28.0% | 11,264 | 0.0% | 0.17% | -22.6% |
| Q2 2015 | $257,000 | +131.5% | 11,264 | +54.8% | 0.22% | +130.9% |
| Q1 2015 | $111,000 | +26.1% | 7,275 | 0.0% | 0.09% | +32.4% |
| Q4 2014 | $88,000 | +7.3% | 7,275 | 0.0% | 0.07% | +2.9% |
| Q3 2014 | $82,000 | -6.8% | 7,275 | 0.0% | 0.07% | -5.5% |
| Q2 2014 | $88,000 | +3.5% | 7,275 | 0.0% | 0.07% | +1.4% |
| Q1 2014 | $85,000 | – | 7,275 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |